Axel Gaston Glasmacher
Chairman presso 4D PHARMA PLC
Posizioni attive di Axel Gaston Glasmacher
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| 4D PHARMA PLC | Independent Dir/Board Member | 08/01/2019 | - |
| Chairman | 17/04/2020 | - | |
| Director/Board Member | 08/01/2019 | 17/04/2020 | |
| RYVU THERAPEUTICS S.A. | Director/Board Member | 01/10/2019 | - |
| ACTIVE BIOTECH AB | Director/Board Member | 01/01/2020 | - |
| Independent Dir/Board Member | 01/01/2020 | - | |
| The Cancer Drug Development Forum | Director/Board Member | - | - |
| Treasurer | - | - | |
| AG Life Science Consulting Gmbh & Co. Kg | Chief Executive Officer | - | - |
| Director/Board Member | 01/03/2018 | - | |
| Glasmacher Verwaltungs GmbH | Chief Executive Officer | - | - |
| Director/Board Member | - | - | |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Board Member | 01/07/2021 | - |
Storia della carriera di Axel Gaston Glasmacher
Precedenti posizioni note di Axel Gaston Glasmacher
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELGENE | Chief Tech/Sci/R&D Officer | 01/05/2006 | 01/02/2018 |
Formazione di Axel Gaston Glasmacher
| University of Bonn | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 4 |
| Stati Uniti | 3 |
| Svezia | 2 |
Posizioni
| Director/Board Member | 7 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| Aziende private | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| The Cancer Drug Development Forum | |
| AG Life Science Consulting Gmbh & Co. Kg | |
| Glasmacher Verwaltungs GmbH | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
